Transfemoral Transcaval Core-Needle Liver Biopsy: An Alternative to Transjugular Liver Biopsy

Jacob Cynamon, Cyrus Shabrang, Yosef S. Golowa, Amit Daftari, Oren Herman, Marcy B. Jagust

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Purpose To describe the technique and outcome of transfemoral transcaval (TFTC) core-needle liver biopsies. Materials and Methods Retrospective chart review was performed on 121 patients who underwent transvenous liver biopsies at a single institution between February 2014 and July 2015, yielding 66 total TFTC liver biopsies for review (65.2% male; mean age, 53.2 y ± 15.0). From August 2014 through July 2015, TFTC biopsies accounted for 64 of 77 (83%) transvenous biopsies. Hepatic tissue was obtained directly through the intrahepatic inferior vena cava from a femoral venous approach. Procedural complications were classified according to Society of Interventional Radiology guidelines. Results Of the 66 biopsies, technical success was achieved in 64 cases (97.0%). Histopathologic diagnoses were made in 63 cases (95.5%). Fragmented or limited specimens in which a pathologic diagnosis was still made occurred in four cases (6.1%). Complications occurred in two cases (3.0%). Venous pressure measurements were requested in 60 cases, and all were successfully obtained. Conclusions TFTC core-needle liver biopsies are feasible and safe as demonstrated in this series of patients.

Original languageEnglish (US)
Pages (from-to)370-375
Number of pages6
JournalJournal of Vascular and Interventional Radiology
Volume27
Issue number3
DOIs
Publication statusPublished - Mar 1 2016

    Fingerprint

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this